Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NALAregistrySABI2026 | Registry Identifier | NALAregistrySABI ; Digital Phenotyping of Stroke Access Barriers |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to identify and quantify the non-clinical barriers (social, transport, and knowledge-based) that delay patient arrival at the hospital during an Acute Ischemic Stroke. By utilizing a multimodal approach that combines a validated patient questionnaire (SABI Tool), Geographic Information Systems (GIS) analysis, and biological markers (infarct volume), the investigators seek to develop a Machine Learning model capable of predicting high-risk phenotypes for pre-hospital delay. The ultimate goal is to validate "Social Determinants of Health" against objective biological outcomes.
Despite advances in stroke reperfusion therapies (thrombectomy and thrombolysis), pre-hospital delays remain the primary cause of preventable disability. Current triage systems rely heavily on clinical severity scales but fail to account for Social Determinants of Health (SDOH) that dictate onset-to-door times.
This is a prospective, observational, single-center cohort study designed to validate the "Stroke Access Barrier Identification" (SABI) tool using a "Triangulation Strategy."
The study employs three distinct data sources:
Subjective: Administration of the SABI questionnaire to assess cognitive, physical, and structural barriers.
Geospatial (Objective): Network-based GIS analysis to calculate precise drive-time isochrones and public transit density, validating patient reports of transport difficulty.
Biological (The "Anchor"): Correlation of barrier scores with Infarct Core Volume (measured via CT-Perfusion/MRI) and 90-day functional outcomes.
Data will be processed using interpretable Machine Learning algorithms (Random Forest / XGBoost) and SHAP (SHapley Additive exPlanations) values to identify the specific social features that most strongly predict delayed presentation and increased brain tissue loss.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Acute Ischemic Stroke (AIS) Patients | Acute Ischemic Stroke (AIS) Patients This cohort consists of adult patients presenting to the Emergency Department with a confirmed clinical and radiological diagnosis of Acute Ischemic Stroke. The group encompasses a continuous spectrum of arrival times, subsequently stratified during analysis into "Early Arrivers" (presenting within the therapeutic window, typically < 4.5 hours) and "Late Arrivers" (presenting after the therapeutic window). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Targeted Stroke Systems of Care Training (SABI-Guided) | Behavioral | Implementation of targeted barrier-reduction strategies at selected stroke centers based on baseline SABI profiles. The primary intervention consists of EMS Training Programs focused on stroke recognition, triage protocols, and rapid transport to Mechanical Thrombectomy (MT) capable centers. Comparator/Control: Pre-intervention period (historical control) where standard of care was utilized without the targeted SABI-guided training. Post-Intervention: Assessment of MT utilization rates and SABI scores following the implementation of the training modules. |
| Measure | Description | Time Frame |
|---|---|---|
| Correlation of SABI Score with Infarct Core Volume (The Biological Anchor) | To validate if subjective barriers correlate with objective physiological damage. The total score on the SABI questionnaire (Scale 0-100, higher scores indicate higher barriers) will be correlated with the admission Infarct Core Volume (measured in milliliters via automated CT-Perfusion software). | Baseline (Admission Imaging) |
| Measure | Description | Time Frame |
|---|---|---|
| Predictive Accuracy of ML Model for "High-Risk" Delay | Sensitivity and Specificity of the XGBoost Machine Learning model in classifying patients as "Early Arrivers" vs. "Late Arrivers" (defined as >4.5 hours from Last Known Well) using combined clinical and SABI variables. | Baseline through Study Completion (12 months) |
Not provided
Inclusion Criteria:
Patient or Legally Authorized Representative (LAR) able to provide informed consent.
Verifiable residential address (required for GIS analysis).
Exclusion Criteria:
Not provided
Not provided
Not provided
The source population comprises patients recruited from 12 tertiary centers across the MENA region: Alexandria University, Ain Shams University, and Cairo University (Egypt); Eskisehir Osmangazi University and Dr. Lutfi Kirdar City Hospital (Turkey); Amman Specialized IR Center (Jordan); King Khalid University, King Abdullah Medical City, and Imam Abdulrahman Al Faisal University (Saudi Arabia); Institute National de Neurology (Tunisia); Cleveland Clinic Abu Dhabi (UAE); and Weill Cornell Medicine (Qatar).
This multinational design ensures significant geographic heterogeneity-ranging from the dense urban traffic of Istanbul and Cairo to the mountainous terrain of Abha-which is critical for GIS transport analysis. Additionally, the inclusion of diverse economic and cultural backgrounds supports robust SABI analysis regarding stroke awareness and health-seeking behaviors across the region.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Alexandria Stroke and Neurointervention Center | Alexandria | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Agreement between Subjective Transport Barriers and GIS Metrics |
Cohen's Kappa coefficient measuring agreement between patient-reported "Difficulty with Transport" (SABI Domain 2) and objective "Network Drive Time" calculated via ArcGIS using historical traffic data. |
| Baseline |
| Functional Outcome (mRS) at 90 Days | Correlation between baseline SABI Barrier Score and the Modified Rankin Scale (mRS) score at 90 days. The mRS is a scale from 0 (no symptoms) to 6 (dead). | 90 Days post-discharge |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |